Previous 10 | Next 10 |
home / stock / rmd / rmd articles
ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 4.86% on an annualized basis producing an average annual return of 15.65%. ...
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- When: May 17–22, 2024Where: San Diego Convention Center (SDCC) | ...
Prestige Consumer Healthcare Inc. (NYSE: PBH) delivered fourth-quarter fiscal 2024 earnings per share of $1.02, a 4.7% decline from the year-a...
Inspire Medical Systems, Inc. (NYSE: INSP) delivered a loss per share of 34 cents in first-quarter 2024, narrower than the year-ago period's lo...
Shares of Aon plc (NYSE:AON) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results. ...
U.S. stocks were higher, with the Dow Jones jumping over 150 points on Friday. Shares of Skechers U.S.A., Inc. (NYSE:SKX) rose sharply during Frida...
ResMed (NYSE:RMD) reported better-than-expected third-quarter financial results on Thursday. ResMed posted adjusted earnings of $2.13 per share, be...
Shares of Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) rose sharply in today's pre-market trading the company posted upbeat results for its firs...
Tech earnings could come to the market’s rescue as traders remain jittery about the outcome of key inflation data due on Friday. AI giants&nb...
News, Short Squeeze, Breakout and More Instantly...
2024-06-29 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. He...
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA) Prevalence of OSA in the United States expected to increase 26.7%...